DK166320C - Eddikesyreesteren af haloperidol, fremgangsmaade til fremstilling heraf og farmaceutiske kompositioner deraf - Google Patents

Eddikesyreesteren af haloperidol, fremgangsmaade til fremstilling heraf og farmaceutiske kompositioner deraf

Info

Publication number
DK166320C
DK166320C DK479587A DK479587A DK166320C DK 166320 C DK166320 C DK 166320C DK 479587 A DK479587 A DK 479587A DK 479587 A DK479587 A DK 479587A DK 166320 C DK166320 C DK 166320C
Authority
DK
Denmark
Prior art keywords
haloperidol
pharmaceutical compositions
acetic acid
estate
preparing
Prior art date
Application number
DK479587A
Other languages
English (en)
Other versions
DK479587A (da
DK166320B (da
DK479587D0 (da
Inventor
Jens Kristian Perregaard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of DK479587D0 publication Critical patent/DK479587D0/da
Publication of DK479587A publication Critical patent/DK479587A/da
Publication of DK166320B publication Critical patent/DK166320B/da
Application granted granted Critical
Publication of DK166320C publication Critical patent/DK166320C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/52Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
DK479587A 1986-09-11 1987-09-11 Eddikesyreesteren af haloperidol, fremgangsmaade til fremstilling heraf og farmaceutiske kompositioner deraf DK166320C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8621892 1986-09-11
GB868621892A GB8621892D0 (en) 1986-09-11 1986-09-11 Organic compound

Publications (4)

Publication Number Publication Date
DK479587D0 DK479587D0 (da) 1987-09-11
DK479587A DK479587A (da) 1988-03-12
DK166320B DK166320B (da) 1993-04-05
DK166320C true DK166320C (da) 1993-08-23

Family

ID=10604021

Family Applications (1)

Application Number Title Priority Date Filing Date
DK479587A DK166320C (da) 1986-09-11 1987-09-11 Eddikesyreesteren af haloperidol, fremgangsmaade til fremstilling heraf og farmaceutiske kompositioner deraf

Country Status (16)

Country Link
US (1) US4855307A (da)
EP (1) EP0260070B1 (da)
JP (1) JPS6377857A (da)
AT (1) ATE92917T1 (da)
AU (1) AU591334B2 (da)
DE (1) DE3786966T2 (da)
DK (1) DK166320C (da)
ES (1) ES2058120T3 (da)
FI (1) FI88155C (da)
GB (1) GB8621892D0 (da)
IE (1) IE60902B1 (da)
IL (1) IL83819A (da)
NO (1) NO169893C (da)
NZ (1) NZ221711A (da)
PT (1) PT85678B (da)
ZA (1) ZA876819B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3742580C1 (de) * 1987-12-16 1989-05-11 Schaper & Bruemmer Gmbh Verwendung des alpha,alpha-Diphenyl-alpha-(3-carboxy-propionyloxy)-essigsaeure-4-(N-methylpiperidyl)-esters zur Behandlung hypertoner Funktionszustaende im Bereich der Harnblase
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
DK238190D0 (da) * 1990-10-03 1990-10-03 Lundbeck & Co As H Depotderivater
ATE348808T1 (de) 2000-03-06 2007-01-15 Acadia Pharm Inc Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten
EP1787984B1 (en) * 2000-03-06 2016-10-19 Acadia Pharmaceuticals Inc. Azacyclic compounds for use in the treatment of serotonin related diseases
WO2003057698A2 (en) 2001-12-28 2003-07-17 Acadia Pharmaceuticals, Inc. Spiroazacyclic compounds as monoamine receptor modulators
US7538222B2 (en) 2002-06-24 2009-05-26 Acadia Pharmaceuticals, Inc. N-substituted piperidine derivatives as serotonin receptor agents
WO2004000808A2 (en) 2002-06-24 2003-12-31 Acadia Pharmaceuticals Inc. N-substituted piperidine derivatives as serotonin receptor agents
US7253186B2 (en) 2002-06-24 2007-08-07 Carl-Magnus Andersson N-substituted piperidine derivatives as serotonin receptor agents
SI1587789T1 (sl) 2003-01-16 2009-02-28 Acadia Pharm Inc Selektivni inverzni agonisti serotoninskega 2A/2Creceptorja kot terapevtiki za nevrodegenerativne bolezni
US7820695B2 (en) 2004-05-21 2010-10-26 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
US20050261278A1 (en) 2004-05-21 2005-11-24 Weiner David M Selective serotonin receptor inverse agonists as therapeutics for disease
ES2412207T3 (es) 2004-09-27 2013-07-10 Acadia Pharmaceuticals Inc. Forma cristalina de hemitartrato de N-(4-fluorobencil)-N-(1-metilpiperidin-4-il)-N'-(4-(2-metilpropiloxi)fenilmetil)carbamida
US7790899B2 (en) 2004-09-27 2010-09-07 Acadia Pharmaceuticals, Inc. Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
AU2008228833B9 (en) 2007-03-19 2013-10-24 Acadia Pharmaceuticals Inc. Combinations of 5-HT2A inverse agonists and antagonists with antipsychotics
HUE055763T2 (hu) 2015-07-20 2021-12-28 Acadia Pharm Inc Eljárás N-(4-fluorbenzil)-N-(1-metilpiperidin-4-il)-N'-(4-(2-metil-propil-oxi)fenil-metil)karbamid vagy ennek tartarát-sója és C polimorf formája elõállítására
WO2017165635A1 (en) 2016-03-25 2017-09-28 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome p450 modulators
US10953000B2 (en) 2016-03-25 2021-03-23 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
US11464768B2 (en) 2016-12-20 2022-10-11 Acadia Pharmaceuticals Inc. Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis
WO2018200977A1 (en) 2017-04-28 2018-11-01 Acadia Pharmaceuticals Inc. Pimavanserin for treating impulse control disorder
EP3675827A1 (en) 2017-08-30 2020-07-08 Acadia Pharmaceuticals Inc. Formulations of pimavanserin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB895309A (en) * 1959-11-18 1962-05-02 Res Lab Dr C Janssen Nv Pyrrolidine and piperidine derivatives
US3408356A (en) * 1965-08-31 1968-10-29 Squibb & Sons Inc Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like
DE1695194A1 (de) * 1966-07-11 1971-03-18 Hoffmann La Roche Verfahren zur Herstellung von Piperidinderivaten
US4070473A (en) * 1973-01-26 1978-01-24 Ab Ferrosan Piperidino-butyrophenones
JPS568318A (en) * 1979-06-28 1981-01-28 Janssen Pharmaceutica Nv Non oral long acting composition of haloperidol and bromperidol derivative

Also Published As

Publication number Publication date
IE60902B1 (en) 1994-08-24
US4855307A (en) 1989-08-08
EP0260070B1 (en) 1993-08-11
JPS6377857A (ja) 1988-04-08
FI873924L (fi) 1988-03-12
ATE92917T1 (de) 1993-08-15
PT85678B (pt) 1990-05-31
PT85678A (en) 1987-10-01
DK479587A (da) 1988-03-12
AU7823287A (en) 1988-03-17
IL83819A0 (en) 1988-02-29
NO873785L (no) 1988-03-14
DE3786966T2 (de) 1994-03-17
AU591334B2 (en) 1989-11-30
EP0260070A1 (en) 1988-03-16
IL83819A (en) 1992-02-16
FI88155C (fi) 1993-04-13
NO169893C (no) 1992-08-19
GB8621892D0 (en) 1986-10-15
DK166320B (da) 1993-04-05
ZA876819B (en) 1988-06-29
NO169893B (no) 1992-05-11
DK479587D0 (da) 1987-09-11
FI88155B (fi) 1992-12-31
NZ221711A (en) 1989-11-28
ES2058120T3 (es) 1994-11-01
IE872366L (en) 1988-03-11
FI873924A0 (fi) 1987-09-10
NO873785D0 (no) 1987-09-10
DE3786966D1 (de) 1993-09-16

Similar Documents

Publication Publication Date Title
DK166320C (da) Eddikesyreesteren af haloperidol, fremgangsmaade til fremstilling heraf og farmaceutiske kompositioner deraf
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
DK249680A (da) Fremgangsmaade til fremstilling af 4-substituerede 3-hydroxy-3-pyrrolin-2,5-dioner
DK384280A (da) Fremgangsmaade til fremstilling af substituerede 4-thiazolyl-3-hydroxy-3-pyrrolin-2,5-dioner
ATE103315T1 (de) Verwendung haertbarer cycloaliphaten-derivate in duebelmassen.
DE69122866D1 (de) Herstellung von substituierten piperidinen
DK0614362T5 (da) Farmaceutiske præparater på basis af ebastin eller dermed analoge forbindelser
DK157013C (da) Analogifremgangsmaade til fremstilling af fluorholdige 1,4-dihydropyridiner eller farmaceutisk acceptable syreadditionssalte deraf
DE69330905D1 (de) Verfahren zur Herstellung von N-substituierten polyhydroxy-stickstoffhaltigen Heterocyclen
DE58905079D1 (de) Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung.
DE69018755D1 (de) Verfahren zur Herstellung von 3-(L-Pyroglutamyl)-L-thiazolidin-4-carbonsäure-Derivaten.
ATE78693T1 (de) Ein dideoxynukleosid enthaltendes arzneimittel.
DE59107262D1 (de) Oxetanone
EP0191724A3 (de) 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DK59281A (da) Fremgangsmaade til fremstilling af phenylpiperazinderivater af 1,3,4-oxadiazolylphenolder
ES535012A0 (es) Un procedimiento para preparar dihidropiridinas
DE58906606D1 (de) Optisch aktive Rhodiumkomplexe von 3,4-Bis(diarylphosphino)-pyrrolidinen und ihre Verwendung zur Herstellung von Phosphinothricin durch asymmetrische Hydrierung.
ES2059767T3 (es) Derivado de 1,4-dihidropiridina.
DE69120705D1 (de) Hydroxymethyl-indolizidine und -chinolizidine
ATE90095T1 (de) Optisch aktive produkte von 20,21dinoreburnamenin-derivaten,verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
DK468385D0 (da) Fremgangsmaade til fremstilling af den optiske d-isomer af diastereomeren aeaae af 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)-ester-5-methylester
SE8505801D0 (sv) 1,4-dihydropyridin-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
FI885487L (fi) Foerfarande foer framstaellning av asparaginsyra-4-(fenylmetyl)-ester.
DE59002266D1 (de) Verwendung von 4-(hydroxydi-phenylmethyl)-1-piperidyl-phenylalkan-derivaten zur herstellung eines antihistaminikums.
DE59208349D1 (de) 2-Arylpropensäuren und ihre Verwendung bei der Herstellung von S-Ketoprofen

Legal Events

Date Code Title Description
PBP Patent lapsed